They also reported that HLA-C*03:04 (40 patients, 120 controls; OR = 3.5, p = 0.010) might be a potential positive marker for CM-related SJS/TEN with SOC, and HLA-C*03:03 (40 patients, 120 controls; OR = 0.10, p = 0.0056) might be a possible indicator of the protection against CM-related SJS/TEN with SOC in Korea (Jun et al., 2019). This evidence concerns the gene HLA-C and toxic epidermal necrolysis.